Wyeth Ends Crucell Talks Before Takeover by Pfizer

Wyeth withdrew from talks to acquire Dutch vaccine-maker Crucell, sending Crucell’s shares tumbling, as the U.S. drugmaker’s own $68 billion takeover by Pfizer neared agreement.
Forex Yard